Clinical Trial Update: Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase 1 study reports the pharmacokinetics of degarelix in Chinese patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• degarelix (degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED